1. Walls, A.C., et al., Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein. Cell, 2020. 181(2): p. 281-292.e6.
2. Zhou, J., et al., Middle East respiratory syndrome coronavirus infection: virus-host cell interactions and implications on pathogenesis. Virol J, 2015. 12: p. 218.
3. Chan, J.F., et al., Middle East respiratory syndrome coronavirus: another zoonotic betacoronavirus causing SARS-like disease. Clin Microbiol Rev, 2015. 28(2): p. 465-522.
4. Muniyappa, R. and S. Gubbi, COVID-19 pandemic, coronaviruses, and diabetes mellitus. Am J Physiol Endocrinol Metab, 2020. 318(5): p. E736-e741.
5. Li, B., et al., Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China. Clin Res Cardiol, 2020. 109(5): p. 531-538.
6. Maddaloni, E., et al., Clinical features of patients with type 2 diabetes with and without Covid-19: A case control study (CoViDiab I). Diabetes Res Clin Pract, 2020. 169: p. 108454.
7. Andersen, C.J., K.E. Murphy, and M.L. Fernandez, Impact of Obesity and Metabolic Syndrome on Immunity. Adv Nutr, 2016. 7(1): p. 66-75.
8. Francisco, V., et al., Adipokines: Linking metabolic syndrome, the immune system, and arthritic diseases. Biochem Pharmacol, 2019. 165: p. 196-206.
9. Faber, D.R., P.G. de Groot, and F.L. Visseren, Role of adipose tissue in haemostasis, coagulation and fibrinolysis. Obes Rev, 2009. 10(5): p. 554-63.
10. Kulcsar, K.A., et al., Comorbid diabetes results in immune dysregulation and enhanced disease severity following MERS-CoV infection. JCI Insight, 2019. 4(20).
11. Yang, J.K., et al., Plasma glucose levels and diabetes are independent predictors for mortality and morbidity in patients with SARS. Diabet Med, 2006. 23(6): p. 623-8.
12. Sardu, C., et al., Outcomes in Patients With Hyperglycemia Affected by COVID-19: Can We Do More on Glycemic Control? Diabetes Care, 2020. 43(7): p. 1408-1415.
13. Sardu, C., et al., Hyperglycaemia on admission to hospital and COVID-19. Diabetologia, 2020. 63(11): p. 2486-2487.
14. Schuetz, P., P. Castro, and N.I. Shapiro, Diabetes and sepsis: preclinical findings and clinical relevance. Diabetes Care, 2011. 34(3): p. 771-8.
15. Drucker, D.J., Coronavirus Infections and Type 2 Diabetes-Shared Pathways with Therapeutic Implications. Endocr Rev, 2020. 41(3).
16. Ryan, D.H., E. Ravussin, and S. Heymsfield, COVID 19 and the Patient with Obesity - The Editors Speak Out. Obesity (Silver Spring), 2020. 28(5): p. 847.
17. Alberti, K.G. and P.Z. Zimmet, Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med, 1998. 15(7): p. 539-53.
18. [The protocol for prevention, diagnosis and treatment of liver injury in coronavirus disease 2019]. Zhonghua Gan Zang Bing Za Zhi, 2020. 28(3): p. 217-221.
19. Knapp, S., Diabetes and infection: is there a link?--A mini-review. Gerontology, 2013. 59(2): p. 99-104.
20. Schoen, K., et al., Spectrum of clinical and radiographic findings in patients with diagnosis of H1N1 and correlation with clinical severity. BMC Infect Dis, 2019. 19(1): p. 964.
21. Banik, G.R., et al., Risk factors for severity and mortality in patients with MERS-CoV: Analysis of publicly available data from Saudi Arabia. Virol Sin, 2016. 31(1): p. 81-4.
22. Huang, I., M.A. Lim, and R. Pranata, Diabetes mellitus is associated with increased mortality and severity of disease in COVID-19 pneumonia - A systematic review, meta-analysis, and meta-regression. Diabetes Metab Syndr, 2020. 14(4): p. 395-403.
23. Soewondo, P., A. Ferrario, and D.L. Tahapary, Challenges in diabetes management in Indonesia: a literature review. Global Health, 2013. 9: p. 63.
24. Tahapary, D.L. and P. Soewondo, Burden of metabolic diseases in Indonesia: an even more critical issue during COVID-19 pandemic. Medical Journal of Indonesia, 2020. 29(4): p. 347-9.
25. Suastika, K., The challenges of metabolic disorders in Indonesia: focus on metabolic syndrome, prediabetes, and diabetes. Medical Journal of Indonesia, 2020. 29(4): p. 350-3.
26. Peric, S. and T.M. Stulnig, Diabetes and COVID-19 : Disease-Management-People. Wien Klin Wochenschr, 2020. 132(13-14): p. 356-361.
27. Li, G., et al., Clinical Characteristics of Diabetic Patients with COVID-19. J Diabetes Res, 2020. 2020: p. 1652403.
28. Walker, P.G.T., et al., The impact of COVID-19 and strategies for mitigation and suppression in low- and middle-income countries. Science, 2020. 369(6502): p. 413-422.